IP Library Granted Patent US 9,394,435
Granted Patent B2
US 9,394,435 · App. 14/457,801 · Granted Jul 19, 2016

Crosslinked zwitterionic hydrogels

Inventors: Shaoyi Jiang (Redmond, WA); Hong Xue (Pleasanton, CA); Wei Yang (Seattle, WA); Louisa R. Carr (Schenectady, NY)
Assignee: University of Washington through its Center for Commercialization
C08L33/10A61K41/0019A61L27/34A61L27/52A61L29/085A61L29/145A61L31/10A61L31/145C07C229/12C08F26/02C08L2201/54C08L2312/00Y10T428/31786
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,394,435
App. No.
14/457,801
Granted
Jul 19, 2016
Kind
B2
Abstract

Zwitterionic crosslinking agents, crosslinked zwitterionic hydrogels prepared from copolymerization of zwitterionic monomers with the zwitterionic crosslinking agent, methods for making crosslinked zwitterionic hydrogels, and devices that include and methods that use the crosslinked zwitterionic hydrogels.

Claims (43)

1. A crosslinked hydrogel, comprising a crosslinked polymer having repeating units and a plurality of crosslinks, wherein each crosslink is represented by the formula:

wherein

R 1 and R 2 are independently selected from the group consisting of hydrogen, fluorine, trifluoromethyl, C1-C6 alkyl, and C6-C12 aryl groups;

R 3 is selected from the group consisting of C1-C6 alkyl, C6-C12 aryl, CH 2 ═C(R 1 )-L 1 -, CH 2 ═C(R 2 )-L 2 -, or R 3 is the residual portion of a third crosslink, -L 1 -CR 1 —CH 2 — or -L 2 -CR 2 —CH 2 —;

L 1 and L 2 are independently selected from the group consisting of —C(═O)O—(CH 2 ) n — and —C(═O)NH—(CH 2 ) n —, wherein n is an integer from 1 to 20;

L 3 is —(CH 2 ) n —, where n is an integer from 1 to 20;

A 1 is C, S, SO, P, or PO;

x is an integer from about 5 to about 10,000;

X − is the counter ion associated with the N + cationic center; and

M + is a counterion associated with the (A=O)O − anionic center.

2. The hydrogel of claim 1 , wherein R 1 , R 2 , and R 3 are independently selected from the group consisting of C1-C3 alkyl.

3. The hydrogel of claim 1 , wherein L 1 and L 2 are —C(═O)O—(CH 2 ) n —, wherein n is 1-6.

4. The hydrogel of claim 1 , wherein L 3 is —(CH 2 ) n —, where n is an integer from 1-6.

5. The hydrogel of claim 1 , wherein A 1 is C or SO.

6. The hydrogel of claim 1 , wherein M + at each occurrence is a metal or organic ion.

7. The hydrogel of claim 1 , wherein X − at each occurrence is selected from the group consisting of halide, carboxylate, alkylsulfonate, sulfate, nitrate, perchlorate, tetrafluoroborate, hexafluorophosphate, trifluoromethylsulfonate, bis(trifluoromethylsulfonyl)amide, lactate, and salicylate.

8. The hydrogel of claim 1 , wherein x is an integer from about 10 to about 1,000.

9. The hydrogel of claim 1 , wherein the hydrogel is a gradient hydrogel.

10. A surface of a substrate, wherein the surface comprises a hydrogel of claim 1 .

11. The surface of claim 10 , wherein the substrate is selected from the group consisting of a medical device, a glucose sensor, a particle, a drug carrier, non-viral gene delivery system, a biosensor, a membrane, an implantable sensor, a subcutaneous sensor, an implant, and a contact lens.

12. The surface of claim 11 , wherein the particle is a nanoparticle.

13. The hydrogel of claim 1 , further comprising a particle encapsulated therein.

14. The hydrogel of claim 13 , wherein the particle is a nanoparticle.

15. The hydrogel of claim 14 , wherein the nanoparticle has a diameter of about 5 nm to about 200 nm.

16. The hydrogel of claim 14 , wherein the nanoparticle is a gold nanoparticle.

17. The hydrogel of claim 14 , wherein the nanoparticle is a polymer-coated nanoparticle.

18. The hydrogel of claim 17 , wherein the nanoparticle is coated with a polymer comprising carboxybetaine methacrylate (CBMA) or oligo(ethylene glycol) methyl ether methacrylate (OEGMA).

19. The hydrogel of claim 1 , wherein each repeating unit has the formula:

wherein

R 4 is selected from the group consisting of hydrogen, fluorine, trifluoromethyl, C1-C6 alkyl, and C6-C12 aryl groups;

R 5 and R 6 are independently selected from the group consisting of hydrogen, alkyl, and aryl, or taken together with the nitrogen to which they are attached form a cationic center;

L 4 is a linker that covalently couples the cationic center [N + (R 5 )(R 6 )] to the polymer backbone [—(CH 2 —CR 4 ) n —];

L 5 is a linker that covalently couples the anionic center [A 2 (═O)—O − ] to the cationic center;

A 2 is C, S, SO, P, or PO;

M + is a counterion associated with the (A 2 =O)O − anionic center;

X − is a counter ion associated with the cationic center;

n is an integer from 5 to about 10,000.

20. The hydrogel of claim 19 , wherein R4, R5, and R6 are independently selected from the group consisting of C1-C3 alkyl.

21. The hydrogel of claim 19 , wherein L4 is selected from the group consisting of —C(═O)O—(CH2)n- and —C(═O)NH—(CH2)n-, wherein n is an integer from 1 to 20.

22. The hydrogel of claim 19 , wherein L5 is —(CH2)n-, where n is an integer from 1 to 20.

23. The hydrogel of claim 19 , wherein n is an integer from 10 to about 1,000.

24. The hydrogel of claim 19 , wherein M+ at each occurrence is a metal or organic ion.

25. The hydrogel of claim 19 , wherein X— at each occurrence is selected from the group consisting of halide, carboxylate, alkylsulfonate, sulfate, nitrate, perchlorate, tetrafluoroborate, hexafluorophosphate, trifluoromethylsulfonate, bis(trifluoromethylsulfonyl)amide, lactate, and salicylate.

Assignments (1)
CONFIRMATORY LICENSE Recorded Aug 7, 2015
From: WASHINGTON, UNIVERSITY OF
To: NAVY, SECRETARY OF THE UNITED STATES OF AMERICA
Reel/Frame 036333/0595 →
Continuity (4)
Division 13463648 · May 3, 2012
Continuation PCTUS2010055875 · Nov 8, 2010
Provisional Application 61259074 · Nov 6, 2009
Related Publication 20150037598A1 · Feb 5, 2015